Brain atrophy in clinically early relapsing-remitting multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

http://www.wikidata.org/entity/Q52046432

about

Association of retinal and macular damage with brain atrophy in multiple sclerosis Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment The Neurophysiologist Perspective into MS Plasticity The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis Clinical correlates of grey matter pathology in multiple sclerosis The topographical model of multiple sclerosis: A dynamic visualization of disease course Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes Revisiting brain atrophy and its relationship to disability in multiple sclerosis A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.Clinical use of brain volumetry.Bringing CLARITY to gray matter atrophy.Current and new directions in MRI in multiple sclerosis Thalamus pathology in multiple sclerosis: from biology to clinical application.Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.Clinical-magnetic resonance imaging correlations in multiple sclerosis.Neuroinflammation - using big data to inform clinical practice.Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis Subtraction MR images in a multiple sclerosis multicenter clinical trial setting.Multiple sclerosis lesions: insights from imaging techniques.A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosis.Reduction in parvalbumin-positive interneurons and inhibitory input in the cortex of mice with experimental autoimmune encephalomyelitis Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis Automated White Matter Hyperintensity Detection in Multiple Sclerosis Using 3D T2 FLAIR.Gray matter imaging in multiple sclerosis: what have we learned?Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.A hybrid geometric-statistical deformable model for automated 3-D segmentation in brain MRI.Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.Gray matter atrophy in multiple sclerosis: a longitudinal study.Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study.Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis.Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.

P2860

Q21135504-43ACB561-5180-41ED-87DA-3644400A7AD7 Q24684364-7775DD19-538C-4468-AE3F-CE98B9C21E70 Q26782926-5EA2786D-0A7A-4994-84B5-96A5E6EA59CF Q26824991-C33A6031-7D25-4ED7-913E-D3B11E2EF781 Q26999302-136D34AC-FE80-4D3A-9D47-574FBC009716 Q27312133-EA49B431-ED6E-4623-82D6-3C5DC9F57368 Q28267527-61D7F3E4-DB4C-429A-B1EC-058C9AA4659E Q28729713-B26E6DAF-6058-4434-82B6-A602ADFCBFD6 Q28729953-BB154F15-9237-4429-BB76-4F75F7E05A00 Q30525646-B96FDA3A-0B37-4584-BEA5-6BB0477703E7 Q30582479-B4BEFCB8-5009-4279-9EDA-920BA077C798 Q30651109-3C58F9FD-7C46-457A-84BD-558D9B85A0C8 Q30659431-83E73066-666F-4A7B-AE78-BA9069134CD0 Q30871067-3A4BD071-D25A-4F22-9A60-2A9BCABAEF67 Q30983016-14741B99-2196-4B69-B182-9C367FE14011 Q31027945-D3BCAA9B-0244-43C4-BDC6-A65E87D400D5 Q31142833-588F1E06-F84E-4EC3-B08F-6F2976A58006 Q33339985-3B64CE42-2823-4C55-B86B-D6241CC02997 Q33387539-9B200341-7251-4C46-8D22-D99E3EE1A415 Q33505423-DACBF05B-8102-4055-B491-B66F9D5ED2B0 Q33738609-77D43D16-AF2E-44E5-9075-B9BC2E8599FC Q33749413-FD07FC99-4D7C-4929-B4AB-A4415729E260 Q33907522-ED405013-73E6-4DD9-A25E-722E689CBCE6 Q34033270-F423DB70-BE32-443E-BF58-DDC46D70A2AA Q34094761-05FB5B09-2CC3-4716-A460-7C4D91E5D0E5 Q34505106-B7DC367A-F2E8-4578-84DC-EB963F529A1A Q34537576-445F65C8-07F3-4415-B318-E2E39B1DD4E1 Q34582216-97DEFF05-1255-4647-B2B9-7828BEF95CAA Q34696441-6A536020-CB28-46DA-8752-AEFB3DB53568 Q34733726-42B37021-4F15-4204-BDE8-888E7D70EEDF Q34746732-488CFB0A-1E51-4B78-9842-E54325D1717E Q34784469-06A5BDDD-A57C-4D09-9273-490CC7E31FEF Q34801849-594710C7-C761-45CD-A0FE-5DB0E531AD15 Q34988315-4B6CD10B-84BB-4D78-B38F-C224B836AAB8 Q35082344-A06A29C8-85E3-4626-9722-B50F0817A80C Q35112343-690F14F6-A958-4DA5-B689-4007F3892211 Q35116652-CF9845F1-5437-40A0-87C8-9469FF34D1A9 Q35470905-67FEA6BE-88E2-451F-BFB6-720E82341CD4 Q35481531-E08FD27C-040A-424C-A329-014F9F9D6463 Q35487283-460E1F47-BAE6-4A16-9E02-22A74F4AABE0

P2860

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

http://www.wikidata.org/entity/Q52046432

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

@en

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

@nl

type

label

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

@en

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

@nl

prefLabel

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

@en

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

@nl

P1433

Q52046432-8D31ED62-6465-4A3A-AD62-8EBB2B86DA0D

P1476

Q52046432-D6F6A976-5C7A-4049-A6A8-3DE9C98E9652

P2093

Q52046432-6A31B57B-34EB-4E59-83F9-44E82E403E9D

Q52046432-A4E7B4DD-259B-4D09-9B75-BF4AEA6491CA

Q52046432-A6C60D7D-9337-4EC7-B7FE-0480B73B3540

Q52046432-C3AF62E5-DAF9-4322-B624-6B6EF7BEEFA3

Q52046432-DF7B0AB8-5249-45E3-8E93-60230802C66A

P2860

Q52046432-0949E09E-52CC-435A-BF18-4A3FEDD3F3EA

Q52046432-1982BE38-AB38-487A-8974-35861C1E4DC1

Q52046432-24ED7D7F-CC6B-4447-B83D-DF34E7DE77B2

Q52046432-253CCDFB-B18A-4C72-8AB4-7574A00975D7

Q52046432-386ECB6C-0791-4E6F-85F0-0FFDC8317E31

Q52046432-3E8BAA44-23F7-4935-B416-35DB791206CD

Q52046432-46FA2886-323A-4BC0-ADB2-F9BAA57A3DB1

Q52046432-48088C74-FEE9-4D73-892B-1B53C8760189

Q52046432-4CC9E615-5C5C-4E51-A11F-F847EC135607

Q52046432-50CEC928-617E-416D-A855-B713AD757D59

P304

Q52046432-B5518327-F097-4963-9A90-A055A6370FA4

P31

Q52046432-7116008A-54CE-4CD6-82F8-1121B95F6113

P356

Q52046432-A02CA3F7-D03B-43FC-A6C2-83D8CF4F4999

P407

Q52046432-DC154DBC-F1C2-433D-86E3-1A56C1D6AC13

P433

Q52046432-1E51DCB1-6819-417B-BB87-E185B6C002D2

P478

Q52046432-5B57BAF1-018E-4E95-95F6-5D181657785E

P50

Q52046432-63602CD4-9E88-4E20-8A96-B15217B17AFC

P577

Q52046432-C67D3980-70CE-44E1-B928-F8505B0D3D8B

P698

Q52046432-F9851774-E471-42C3-B2FC-D5372889ED4C

P921

Q52046432-D41D5876-B6F6-4A56-99B0-2A33F379E47A

Q52046432-F877E904-4E00-4B34-9AEC-55622505B36A

P356

P1433

P1476

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

@en

P2093

A J Thompson

http://www.w3.org/2001/XMLSchema#string

C M Griffin

http://www.w3.org/2001/XMLSchema#string

D H Miller

http://www.w3.org/2001/XMLSchema#string

D T Chard

http://www.w3.org/2001/XMLSchema#string

R Kapoor

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: Results of an international survey

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Voxel-based morphometry--the methods

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

Axonal transection in the lesions of multiple sclerosis

A Wallerian degeneration pattern in patients at risk for MS.

Sex differences in brain aging: a quantitative magnetic resonance imaging study.

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyser.

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.

P304

327-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWF025

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Geoffrey J Parker

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11844733

http://www.w3.org/2001/XMLSchema#string

P921

relapsing-remitting multiple sclerosis

multiple sclerosis